TITLE

No public funding for flu-fighting drug: report

AUTHOR(S)
Sullivan, Patrick
PUB. DATE
March 2001
SOURCE
CMAJ: Canadian Medical Association Journal;3/20/2001, Vol. 164 Issue 6, p859
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Discusses the antiflu drug zanamavir, manufactured by pharmaceutical company GlaxoSmithKline. How the drug is not publicly funded through drug plans in Canada; Comment that the cost of providing zanamavir to the general population would outweigh the benefits.
ACCESSION #
4213919

 

Related Articles

  • Logistic issues and potential prescribing costs associated with use of neuraminidase inhibitors for the treatment of influenza in primary care. Da Silva, Philip R.; Nguyen-Van-Tam, Jonathan S.; Hayward, Andrew C. // Journal of the Royal Society of Medicine;Feb2003, Vol. 96 Issue 2, p66 

    In the UK, the National Institute for Clinical Excellence has recommended the use of neuraminidase inhibitors for elderly and at-risk patients who present with influenza-like illness within 36 hours of symptom onset. However, few data exist to enable primary care trusts to evaluate the logistics...

  • Analysis suggests zanamivir first choice for 'flu in Japan.  // PharmacoEconomics & Outcomes News;1/29/2005, Issue 470, p7 

    Presents the results of a study on the cost effectiveness of several treatment options for influenza or influenza-like illnesses in Tokyo, Japan. Use of a decision-analysis model to estimate the cost effectiveness of oseltamivir, zanamivir and a control agent; Comparison of the time to...

  • OTC product: Beano Meltaways. Smith, Jennifer // Pharmacy Today;Jul2011, Vol. 17 Issue 7, p28 

    The article offers information on various over-the-counter (OTC) products. It says that Beano Meltaways from GlaxoSmithKline prevents bloating and flatulence attributable to nuts, grains, and vegetables with oligosaccharides. The U.S. Food & Drug Administration has approved dexamethasone elixir...

  • Biota: new flu drug may present Tamiflu alternative.  // PharmaWatch: Monthly Review;Sep2009, Vol. 8 Issue 9, p32 

    The article reports on the supposedly alternative for Tamiflu which is the laninamivir. The drug which was manufactured by Daiichi Sankyo and Biota has demonstrated equal efficacy as with the Tamiflu in its Phase III trial conducted in East Asia, though it comes with additional option in the...

  • Zanamir vs Oseltamivir: Which drug is more cost-effective? Poulios, Nick S.; Song, Jeannie; Ackermann, Susan P.; Armstrong, Edward P.; Khan, Zeba M.; Perry, Andrew S.; Perri, Lisa R. // Formulary;May2001, Vol. 36 Issue 5, p383 

    Presents the comparison between the cost-effectiveness of zanamivir and oseltamivir for influenza treatment. Probability of hospitalization in patients with influenza; Possibility of follow-up physician visits following oseltamivir treatment; Use of antibiotics for influenza complications.

  • NEW INDICATIONS.  // Drug Topics;2/17/2003, Vol. 147 Issue 4, p71 

    Features the Lamictal tablets from GlaxoSmithKline PLC in the U.S.

  • H1N1 Vaccine Quantities to Fall Short of Predictions.  // Pharmaceutical Representative;Oct2009, Vol. 39 Issue 10, p8 

    The article reports that the H1N1 influenza vaccines fall short of the predicted doses in the U.S. The vaccines were predicted to reach 120 million doses but only 45 million doses were available in the middle of October 2009 but the government plans for an additional 20 million doses....

  • Olsetamivir for Children 1-3 Years of Age. Jenson, Hal B. // Infectious Disease Alert;Nov2010, Vol. 30 Issue 2, p13 

    A randomized, double-blind, placebo-controlled trial of the efficacy of oral oseltamivir twice daily started within 24 hours of onset of influenza symptoms (fever, plus cough, rhinitis, or sore throat) was conducted in children 1-3 years of age at a single primary care study site in Finland...

  • Sudafed-Co Tablets.  // Royal Society of Medicine: Medicines;2002, p512 

    The article presents information on Sudafed-Co Tablets, a proprietary, non-prescription compound preparation of the sympathomimetic and decongestant pseudoephedrine hydrochloride and the non-narcotic analgesic paracetamol. It can be used for the symptomatic relief of conditions where upper...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics